National CineMedia, Inc. (NCMI) operates the largest cinema advertising network in North America. Five recent, individually attributable price targets were reviewed to build this analysis. Eric Wold of Texas Capital Securities downgraded the stock to Hold with a $1.75 target on November 2, 2026. Drew Crum of B. Riley Securities reiterated a Hold with a $2.50 target on October 19, 2026. Patrick Sholl of Barrington maintained a Buy with a $4.25 target on the same day. Alicia Reese of Wedbush holds a Buy (Outperform) rating with a $5.00 target as of August 12, 2026, while Mike Hickey of Benchmark maintains a Buy with the street-high $6.00 target.
That produces a low-to-high range of $1.75 to $6.00 and a calculated mean of $3.90, which is the central target used throughout this article. The spread is exceptionally wide: cautious analysts see little upside as attendance and advertising demand remain soft, while bulls argue the shares are deeply discounted relative to a recovering box office and the strategic value of diversification. Notably, targets have been falling sharply — the consensus was meaningfully higher a year ago — signaling deteriorating sentiment even among the more optimistic firms. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The latest verified price for NCMI is approximately $1.66, near the low end of a 52-week range of roughly $1.43 to $4.34. Reaching the $3.90 central target implies upside of about 135%, which must be characterized as a very large move rather than a modest or routine recovery. The stock has fallen roughly 57% from recent highs as the market has repriced the company's growth assumptions.
For the target to become attainable, the shares would need to reclaim a series of levels that have acted as resistance, including the $2.00 psychological threshold and the $2.50 area, before approaching the $3.90 mean. That path depends less on any single quarter and more on a sustained re-rating of the business as it proves its post-restructuring strategy.
Several verified factors support a recovery thesis. Second-quarter 2026 revenue rose roughly 12.7% year over year to about $58.4 million, aided by stronger box office results. The company's planned $275 million acquisition of Captivate, a digital out-of-home advertising platform, would diversify revenue beyond the cinema screen and reduce dependence on movie attendance. Analysts at Wedbush and Benchmark have framed their Buy ratings around this "deep-discount recovery" argument, contending that the sell-off overstates the risks to an advertising franchise that remains the category leader in its niche.
The principal obstacles are equally clear. Theater attendance remains the dominant revenue driver, and any softness in the box office translates directly into advertising demand. The November 2 downgrade by Texas Capital Securities to a $1.75 target illustrates how quickly sentiment has soured, and the broader pattern of falling targets across the Street reflects a market that doubts the optimistic estimates. The Captivate transaction, while strategic, will add leverage at a time when the company has suspended its dividend and share buybacks to prioritize debt reduction. With a market capitalization near $150 million and negative trailing EPS (earnings per share), the stock remains sensitive to any execution misstep.
The 52-week range of approximately $1.43 to $4.34 defines the structural picture. The $1.43 area marks a key support level that the stock has tested but not broken. On the upside, the $2.00 psychological level and the $2.50 zone are meaningful resistance areas the shares would need to clear before a move toward the $3.90 target becomes technically credible. The stock's elevated beta of about 1.75 indicates it tends to move more than the broader market, amplifying both rallies and declines.
Analyst price targets generally reflect a research horizon of roughly 12 months, though individual analysts do not always state their exact time frame. Investors focused on this target should watch quarterly results and guidance for evidence that cinema advertising demand is stabilizing, any updates or changes to the Captivate acquisition and its financing, and further analyst revisions — which have recently trended downward. Box office strength and the broader advertising cycle are the external variables most likely to shift the outlook. From what I see, upcoming earnings will be especially telling here.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. Rather than relying on static forecasts, the system helps traders surface opportunities, track existing positions, and spot shifting trends more efficiently. For investors following NCMI or the broader market, these signals offer a way to complement fundamental research with a data-driven, continuously updated view of momentum and risk.
In my own work, I often turn to Tickeron’s AI Daily Buy/Sell Signals to cross-check momentum alongside the fundamental picture for names like NCMI. The platform scans thousands of securities in real time and surfaces signals that help me stay objective when analyst views diverge as sharply as they do here. It is one more layer that keeps the analysis grounded in data rather than sentiment alone.
The question of whether NCMI can reach $3.90 is, in effect, a question about whether the bearish repricing of the stock has gone too far. The central target — the average of five current analyst targets spanning $1.75 to $6.00 — sits about 135% above the latest price, a very large gap that reflects both genuine upside potential and significant uncertainty. Supporting factors include improving cinema revenue and the strategic diversification of the Captivate deal; the obstacles include persistent attendance concerns, rising leverage, and a wave of downward revisions. The unusually wide analyst range underscores that this is not a high-conviction consensus but a divided one, making upcoming earnings, guidance, and acquisition developments the critical data points to monitor.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The RSI Oscillator for NCMI moved out of oversold territory on November 09, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 47 similar instances when the indicator left oversold territory. In 38 of the 47 cases the stock moved higher. This puts the odds of a move higher at 81%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 66 cases where NCMI's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
Following a +7.64% 3-day Advance, the price is estimated to grow further. Considering data from situations where NCMI advanced for three days, in 181 of 246 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
NCMI may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NCMI as a result. In 75 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.
The Moving Average Convergence Divergence Histogram (MACD) for NCMI turned negative on October 22, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 36 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NCMI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for NCMI entered a downward trend on November 04, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.445) is normal, around the industry mean (-1.802). P/E Ratio (-19.750) is within average values for comparable stocks, (21.593). Projected Growth (PEG Ratio) (0.850) is also within normal values, averaging (1.501). Dividend Yield (0.076) settles around the average of (0.084) among similar stocks. P/S Ratio (0.879) is also within normal values, averaging (1.860).
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 89 (best 1 - 100 worst), indicating slightly worse than average price growth. NCMI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 91 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NCMI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a provider of advertising, business meetings, event services and third-party theatre circuits
Industry AdvertisingMarketingServices